206 related articles for article (PubMed ID: 19069677)
41. Adiponectin multimer distribution in patients with familial combined hyperlipidemia.
Koenen TB; van Tits LJ; Holewijn S; Lemmers HL; den Heijer M; Stalenhoef AF; de Graaf J
Biochem Biophys Res Commun; 2008 Nov; 376(1):164-8. PubMed ID: 18762168
[TBL] [Abstract][Full Text] [Related]
42. Insulin resistance and oxidative stress in familial combined hyperlipidemia.
Martinez-Hervas S; Fandos M; Real JT; Espinosa O; Chaves FJ; Saez GT; Salvador A; Cerdá C; Carmena R; Ascaso JF
Atherosclerosis; 2008 Aug; 199(2):384-9. PubMed ID: 18164710
[TBL] [Abstract][Full Text] [Related]
43. Familial combined hyperlipidemia: controversial aspects of its diagnosis and pathogenesis.
Aguilar Salinas CA; Zamora M; Gómez-Díaz RA; Mehta R; Gómez Pérez FJ; Rull JA
Semin Vasc Med; 2004 May; 4(2):203-9. PubMed ID: 15478042
[TBL] [Abstract][Full Text] [Related]
44. Nutrition, body weight and deterioration of familial combined hyperlipidemia.
Koprovicová J; Kollár J; Petrásová D
Coll Antropol; 2006 Dec; 30(4):777-82. PubMed ID: 17243549
[TBL] [Abstract][Full Text] [Related]
45. Familial combined hyperlipidemia: upstream transcription factor 1 and beyond.
Lee JC; Lusis AJ; Pajukanta P
Curr Opin Lipidol; 2006 Apr; 17(2):101-9. PubMed ID: 16531745
[TBL] [Abstract][Full Text] [Related]
46. Diagnosis of familial combined hyperlipidemia based on lipid phenotype expression in 32 families: results of a 5-year follow-up study.
Veerkamp MJ; de Graaf J; Bredie SJ; Hendriks JC; Demacker PN; Stalenhoef AF
Arterioscler Thromb Vasc Biol; 2002 Feb; 22(2):274-82. PubMed ID: 11834528
[TBL] [Abstract][Full Text] [Related]
47. Familial combined hyperlipoproteinemia. Evidence for a role of growth hormone deficiency in effecting its manifestation.
Merimee TJ
J Clin Invest; 1980 Apr; 65(4):829-35. PubMed ID: 6987267
[TBL] [Abstract][Full Text] [Related]
48. [Postprandial changes of blood lipid after ordinary Chinese diet and the influencing factors thereof].
Fu ZF; Liu ML
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):260-2. PubMed ID: 19552844
[TBL] [Abstract][Full Text] [Related]
49. Low fasting triglycerides: hallmark of the healthy large hip?
Ruige JB; Van Gaal LF
Obesity (Silver Spring); 2009 Aug; 17(8):1621-6. PubMed ID: 19247283
[TBL] [Abstract][Full Text] [Related]
50. Association of soluble intercellular adhesion molecule-1 with insulin resistance and metabolic syndrome in Taiwanese.
Hsu LA; Ko YL; Wu S; Teng MS; Chou HH; Chang CJ; Chang PY
Metabolism; 2009 Jul; 58(7):983-8. PubMed ID: 19394054
[TBL] [Abstract][Full Text] [Related]
51. [Familial combined hyperlipidemia - the most common genetic dyslipidemia in population and in patients with premature atherothrombotic cardiovascular disease].
Vaverková H; Karásek D
Vnitr Lek; 2018; 64(1):25-29. PubMed ID: 29498872
[TBL] [Abstract][Full Text] [Related]
52. [Secondary disorders of lipid metabolism, metabolic syndrome and familial combined hyperlipidemia].
Steinmetz A; Schäfer JR
Wien Med Wochenschr; 1994; 144(12-13):299-307. PubMed ID: 8650933
[TBL] [Abstract][Full Text] [Related]
53. [Apolipoprotein B is associated with metabolic syndrome in Chinese pedigrees with familial hyperlipidemia].
Pei WD; Sun YH; Rou WJ; Zu Q; Li Y; Zhang CY; Dai J; Jia YH; Lu ZL; Wu XG; Liu LS; Hui RT
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):313-7. PubMed ID: 15854507
[TBL] [Abstract][Full Text] [Related]
54. Plasma visfatin concentrations increase in both hyper and hypothyroid subjects after normalization of thyroid function and are not related to insulin resistance, anthropometric or inflammatory parameters.
Caixàs A; Tirado R; Vendrell J; Gallart L; Megía A; Simón I; Llauradó G; González-Clemente JM; Giménez-Palop O
Clin Endocrinol (Oxf); 2009 Nov; 71(5):733-8. PubMed ID: 19222486
[TBL] [Abstract][Full Text] [Related]
55. Association between two common polymorphisms of PPARgamma gene and metabolic syndrome families in a Chinese population.
Yang LL; Hua Q; Liu RK; Yang Z
Arch Med Res; 2009 Feb; 40(2):89-96. PubMed ID: 19237017
[TBL] [Abstract][Full Text] [Related]
56. Increased plasma xanthine oxidase activity is related to nuclear factor kappa beta activation and inflammatory markers in familial combined hyperlipidemia.
Martinez-Hervas S; Real JT; Ivorra C; Priego A; Chaves FJ; Pallardo FV; Viña JR; Redon J; Carmena R; Ascaso JF
Nutr Metab Cardiovasc Dis; 2010 Dec; 20(10):734-9. PubMed ID: 19765958
[TBL] [Abstract][Full Text] [Related]
57. Apolipoprotein B versus LDL-cholesterol: Association with other risk factors for atherosclerosis.
Vaverkova H; Karasek D; Novotny D; Jackuliakova D; Lukes J; Halenka M; Frohlich J
Clin Biochem; 2009 Aug; 42(12):1246-51. PubMed ID: 19450572
[TBL] [Abstract][Full Text] [Related]
58. Hyperuricemia and the metabolic syndrome in Hangzhou.
Cai Z; Xu X; Wu X; Zhou C; Li D
Asia Pac J Clin Nutr; 2009; 18(1):81-7. PubMed ID: 19329400
[TBL] [Abstract][Full Text] [Related]
59. SHBG levels correlate with insulin resistance in postmenopausal women.
Akin F; Bastemir M; Alkiş E; Kaptanoglu B
Eur J Intern Med; 2009 Mar; 20(2):162-7. PubMed ID: 19327605
[TBL] [Abstract][Full Text] [Related]
60. Comparison between Turkish Cardiovascular Risk Platform and United States National Cholesterol Education Program Adult Treatment Panel III definitions of the metabolic syndrome in Turkish adults.
Can AS; Ozbayrakçi S; Palaoğlu KE; Bersot TP
J Cardiometab Syndr; 2009; 4(1):26-32. PubMed ID: 19245513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
